Feed TLRY
TL

Tilray Brands, Inc.

TLRY · NASDAQ

$3.99 -3.16% (-$0.13)
1M -7.59%
Market Cap $446.2M
P/E Ratio -
Div. Yield -
ROE 7.95%
Piotroski F-Score Weak
3/9
Valuation
44 /100
Fair
P/S 0.39x
P/B 0.28x
EV/EBITDA 38.16x
Growth
26 /100
Declining
Book val. growth 28.77%
Rev. growth 2.72%
FCF growth N/A
Profitability
10 /100
Weak
Net margin 12.90%
Op. margin 5.18%
FCF margin 9.87%
Quality
6 /100
Poor
ROE 7.95%
ROA 6.40%
Asset turnover 0.50x
Debt
45 /100
Moderate
Current ratio 2.21x
Int. coverage -2.31x
Net debt/EBITDA 10.63x
Stability
15 /100
Unstable
Rev. volatility 23.02%
EPS volatility 428.66%
Profitable years 0

Το Bulios Scoring περιγράφει την ποιότητα και το ιστορικό μιας εταιρείας, όχι τη μελλοντική απόδοση. Ένα υψηλό σκορ δεν είναι σήμα αγοράς. Μάθετε περισσότερα

Ρωτήστε το StockBot για TLRY
Online

Σχετικά με την εταιρεία

Tilray Brands, Inc. is an international company specializing in the production and distribution of medicinal cannabis products and related goods. The company focuses on the cultivation, processing, and manufacturing of medical cannabis with an emphasis on quality and safety. Tilray Brands offers various forms of cannabis products, including therapeutic oil, capsules, flowers, and other preparations designed for medicinal purposes. The company collaborates with physicians and patients to provide high-quality and effective treatment options for various medical conditions. Tilray Brands is also engaged in research and development of new cannabis medicines and therapies. The company is following the growing interest in medicinal cannabis and its potential to improve the health of patients. Tilray Brands, Inc. (TLRY or TLB) shares could be an interesting choice for investors who follow the market for medicinal cannabis products and seek investment opportunities in an international company with a specialized focus on medical cannabis.

Δεν είναι ακόμη διαθέσιμο στη γλώσσα σας, επομένως το κείμενο είναι στα αγγλικά.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Irwin David Simon

Employees

3,595

Headquarters

Leamington

Επερχόμενα γεγονότα

08 ΟΚΤ

Earnings

Upcoming earnings report

22d

Χρησιμοποιούμε απαραίτητα cookies για τη λειτουργία του ιστότοπου και προαιρετικά αναλυτικά cookies για τη μέτρηση της χρήσης. Δείτε την Πολιτική απορρήτου μας.